Sana Biotechnology Inc. (SANA)
NASDAQ: SANA
· Real-Time Price · USD
2.65
-0.11 (-3.99%)
At close: Jun 20, 2025, 2:06 PM
-3.99% (1D)
| Bid | 2.64 |
| Market Cap | 596.59M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -208.67M |
| EPS (ttm) | -0.88 |
| PE Ratio (ttm) | -3.01 |
| Forward PE | -3.89 |
| Analyst | Buy |
| Ask | 2.65 |
| Volume | 1,794,281 |
| Avg. Volume (20D) | 3,720,883 |
| Open | 2.83 |
| Previous Close | 2.76 |
| Day's Range | 2.61 - 2.83 |
| 52-Week Range | 1.26 - 7.40 |
| Beta | 1.79 |
About SANA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SANA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SANA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
-17.69%
Sana Biotechnology shares are trading lower. The c...
Unlock content with
Pro Subscription
5 months ago
+160.61%
Sana Biotechnology shares are trading higher after the company on Tuesday announced clinical trial results from its type 1 diabetes study of islet cell transplantation without immunosuppression.
